BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 25855980)

  • 21. Requirement for PRC1 subunit BMI1 in host gene activation by Epstein-Barr virus protein EBNA3C.
    Paschos K; Bazot Q; Lees J; Farrell PJ; Allday MJ
    Nucleic Acids Res; 2019 Apr; 47(6):2807-2821. PubMed ID: 30649516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteasomal inhibition triggers viral oncoprotein degradation via autophagy-lysosomal pathway.
    Gain C; Malik S; Bhattacharjee S; Ghosh A; Robertson ES; Das BB; Saha A
    PLoS Pathog; 2020 Feb; 16(2):e1008105. PubMed ID: 32092124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EBNA3C Directs Recruitment of RBPJ (CBF1) to Chromatin during the Process of Gene Repression in EBV Infected B Cells.
    Kalchschmidt JS; Gillman AC; Paschos K; Bazot Q; Kempkes B; Allday MJ
    PLoS Pathog; 2016 Jan; 12(1):e1005383. PubMed ID: 26751214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines.
    Knight JS; Lan K; Subramanian C; Robertson ES
    J Virol; 2003 Apr; 77(7):4261-72. PubMed ID: 12634383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model.
    Romero-Masters JC; Ohashi M; Djavadian R; Eichelberg MR; Hayes M; Bristol JA; Ma S; Ranheim EA; Gumperz J; Johannsen EC; Kenney SC
    PLoS Pathog; 2018 Aug; 14(8):e1007221. PubMed ID: 30125329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8.
    Banerjee S; Lu J; Cai Q; Saha A; Jha HC; Dzeng RK; Robertson ES
    PLoS Pathog; 2013; 9(5):e1003314. PubMed ID: 23658517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus nuclear protein 3A domains essential for growth of lymphoblasts: transcriptional regulation through RBP-Jkappa/CBF1 is critical.
    Maruo S; Johannsen E; Illanes D; Cooper A; Zhao B; Kieff E
    J Virol; 2005 Aug; 79(16):10171-9. PubMed ID: 16051810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma.
    Anderton E; Yee J; Smith P; Crook T; White RE; Allday MJ
    Oncogene; 2008 Jan; 27(4):421-33. PubMed ID: 17653091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Cooperative Functions of the EBNA3 Proteins Are Central to EBV Persistence and Latency.
    Styles CT; Paschos K; White RE; Farrell PJ
    Pathogens; 2018 Mar; 7(1):. PubMed ID: 29562595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissecting the contribution of EBNA3C domains important for EBV-induced B-cell growth and proliferation.
    Jha HC; Shukla SK; Lu J; Aj MP; Banerjee S; Robertson ES
    Oncotarget; 2015 Oct; 6(30):30115-29. PubMed ID: 26336822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EBNA3C facilitates RASSF1A downregulation through ubiquitin-mediated degradation and promoter hypermethylation to drive B-cell proliferation.
    Zhang S; Pei Y; Lang F; Sun K; Singh RK; Lamplugh ZL; Saha A; Robertson ES
    PLoS Pathog; 2019 Jan; 15(1):e1007514. PubMed ID: 30615685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus nuclear antigen (EBNA) 3A induces the expression of and interacts with a subset of chaperones and co-chaperones.
    Young P; Anderton E; Paschos K; White R; Allday MJ
    J Gen Virol; 2008 Apr; 89(Pt 4):866-877. PubMed ID: 18343826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis.
    Cai Q; Guo Y; Xiao B; Banerjee S; Saha A; Lu J; Glisovic T; Robertson ES
    PLoS Pathog; 2011 Dec; 7(12):e1002418. PubMed ID: 22174681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus nuclear antigen 3C regulated genes in lymphoblastoid cell lines.
    Zhao B; Mar JC; Maruo S; Lee S; Gewurz BE; Johannsen E; Holton K; Rubio R; Takada K; Quackenbush J; Kieff E
    Proc Natl Acad Sci U S A; 2011 Jan; 108(1):337-42. PubMed ID: 21173222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EBNA3C attenuates the function of p53 through interaction with inhibitor of growth family proteins 4 and 5.
    Saha A; Bamidele A; Murakami M; Robertson ES
    J Virol; 2011 Mar; 85(5):2079-88. PubMed ID: 21177815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus EBNA3 proteins bind to the C8/alpha7 subunit of the 20S proteasome and are degraded by 20S proteasomes in vitro, but are very stable in latently infected B cells.
    Touitou R; O'Nions J; Heaney J; Allday MJ
    J Gen Virol; 2005 May; 86(Pt 5):1269-1277. PubMed ID: 15831937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth.
    Maruo S; Wu Y; Ito T; Kanda T; Kieff ED; Takada K
    Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4419-24. PubMed ID: 19237563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Epstein-Barr virus isolated from a lymphoblastoid cell line has a 16-kilobase-pair deletion which includes gp350 and the Epstein-Barr virus nuclear antigen 3A.
    Lee W; Hwang YH; Lee SK; Subramanian C; Robertson ES
    J Virol; 2001 Sep; 75(18):8556-68. PubMed ID: 11507201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr Virus Nuclear Antigen 3C Facilitates Cell Proliferation by Regulating Cyclin D2.
    Pei Y; Singh RK; Shukla SK; Lang F; Zhang S; Robertson ES
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29997218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus latent gene sequences as geographical markers of viral origin: unique EBNA3 gene signatures identify Japanese viruses as distinct members of the Asian virus family.
    Sawada A; Croom-Carter D; Kondo O; Yasui M; Koyama-Sato M; Inoue M; Kawa K; Rickinson AB; Tierney RJ
    J Gen Virol; 2011 May; 92(Pt 5):1032-1043. PubMed ID: 21248177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.